Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TALK · against 1,216 other Healthcare companies
Ranked #81 of 1,217 · scores higher than 93% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including TALK · Click a bar to see the companies
Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | TALK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 22.0% | 6.1% | 80% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 300.0% | 9.7% | 95% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 24.2% | 5.8% | 84% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 81 | 9.2B USD | 93 | 39 | |
| 81 | 1.5B USD | 93 | 32 | |
| 81 | 1.1B USD | 93 | 61 | |
| 81 | 276M SEK (≈$28M) | 93 | 48 | |
| 81 | 871M USD | 93 | 53 | |
| 93 | 287.6B KRW (≈$207M) | 92 | ||
| 93 | 4.6B CNY (≈$639M) | 92 | 68 | |
| 93 | 2.2B USD | 92 | 82 | |
| 93 | 7.3B USD | 92 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score